Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AIStockSavvy Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::72858967.png) Hardik Shah [@AIStockSavvy](/creator/twitter/AIStockSavvy) on x 17.7K followers
Created: 2025-07-09 11:39:20 UTC

$CRL | 𝐂𝐡𝐚𝐫𝐥𝐞𝐬 𝐑𝐢𝐯𝐞𝐫 𝐋𝐚𝐛𝐬 (CRL): Citi upgrades 𝐭𝐨 𝐁𝐮𝐲, raises 𝐏𝐓 𝐭𝐨 $𝟐𝟎𝟎 (𝐟𝐫𝐨𝐦 $𝟏𝟓𝟎)

Analyst sees 𝐝𝐞𝐦𝐚𝐧𝐝 𝐬𝐭𝐫𝐞𝐧𝐠𝐭𝐡, 𝐚𝐜𝐭𝐢𝐯𝐢𝐬𝐭 𝐜𝐚𝐭𝐚𝐥𝐲𝐬𝐭𝐬, and 𝐝𝐢𝐬𝐬𝐢𝐩𝐚𝐭𝐢𝐧𝐠 𝐅𝐃𝐀 𝐟𝐞𝐚𝐫𝐬 as setup for potential beat/raise.

![](https://pbs.twimg.com/media/GvabqJZW8AAeQyM.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942911443831075133/c:line.svg)

**Related Topics**
[$crl](/topic/$crl)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/AIStockSavvy/status/1942911443831075133)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

AIStockSavvy Avatar Hardik Shah @AIStockSavvy on x 17.7K followers Created: 2025-07-09 11:39:20 UTC

$CRL | 𝐂𝐡𝐚𝐫𝐥𝐞𝐬 𝐑𝐢𝐯𝐞𝐫 𝐋𝐚𝐛𝐬 (CRL): Citi upgrades 𝐭𝐨 𝐁𝐮𝐲, raises 𝐏𝐓 𝐭𝐨 $𝟐𝟎𝟎 (𝐟𝐫𝐨𝐦 $𝟏𝟓𝟎)

Analyst sees 𝐝𝐞𝐦𝐚𝐧𝐝 𝐬𝐭𝐫𝐞𝐧𝐠𝐭𝐡, 𝐚𝐜𝐭𝐢𝐯𝐢𝐬𝐭 𝐜𝐚𝐭𝐚𝐥𝐲𝐬𝐭𝐬, and 𝐝𝐢𝐬𝐬𝐢𝐩𝐚𝐭𝐢𝐧𝐠 𝐅𝐃𝐀 𝐟𝐞𝐚𝐫𝐬 as setup for potential beat/raise.

XXXXX engagements

Engagements Line Chart

Related Topics $crl stocks healthcare

Post Link

post/tweet::1942911443831075133
/post/tweet::1942911443831075133